{
  "cik": 1796280,
  "cik_padded": "0001796280",
  "entityName": "Oric Pharmaceuticals, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-064005",
      "filed": "2026-02-23",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 712000.0,
        "cash": 45669000.0,
        "eps_diluted": -1.47,
        "free_cash_flow": -111682000.0,
        "net_income": -129468000.0,
        "operating_cash_flow": -110970000.0,
        "operating_income": -143004000.0,
        "stockholders_equity": 384362000.0,
        "total_assets": 408890000.0,
        "total_liabilities": 24528000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.06381484121739402,
        "roa_avg2y": -0.3790979046369716,
        "roa_period_end": -0.31663283523686075,
        "roe_avg2y": -0.41265753389727866,
        "roe_period_end": -0.3368387093417143
      }
    },
    {
      "accn": "0001193125-26-064005",
      "filed": "2026-02-23",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1188000.0,
        "cash": 59406000.0,
        "eps_diluted": -1.83,
        "free_cash_flow": -113850000.0,
        "net_income": -127847000.0,
        "operating_cash_flow": -112662000.0,
        "operating_income": -142895000.0,
        "stockholders_equity": 243122000.0,
        "total_assets": 274142000.0,
        "total_liabilities": 31020000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.127590263324586,
        "roa_avg2y": -0.4859726047184353,
        "roa_period_end": -0.4663532038140817,
        "roe_avg2y": -0.5472785257164873,
        "roe_period_end": -0.5258553318909848
      }
    },
    {
      "accn": "0001193125-26-064005",
      "filed": "2026-02-23",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 849000.0,
        "cash": 23384000.0,
        "eps_diluted": -1.96,
        "free_cash_flow": -86537000.0,
        "net_income": -100697000.0,
        "operating_cash_flow": -85688000.0,
        "operating_income": -110780000.0,
        "stockholders_equity": 224088000.0,
        "total_assets": 252007000.0,
        "total_liabilities": 27919000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.12458944700296312,
        "roa_avg2y": -0.4034456163546581,
        "roa_period_end": -0.39958017039209226,
        "roe_avg2y": -0.4511120220231655,
        "roe_period_end": -0.44936364285459285
      }
    },
    {
      "accn": "0000950170-25-022273",
      "filed": "2025-02-18",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2078000.0,
        "cash": 66840000.0,
        "eps_diluted": -2.25,
        "free_cash_flow": -77221000.0,
        "net_income": -89122000.0,
        "operating_cash_flow": -75143000.0,
        "operating_income": -91767000.0,
        "stockholders_equity": 222351000.0,
        "total_assets": 247178000.0,
        "total_liabilities": 24827000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.11165679488736277,
        "roa_avg2y": -0.32656187021362354,
        "roa_period_end": -0.3605579784608663,
        "roe_avg2y": -0.35985116902571435,
        "roe_period_end": -0.40081672670687335
      }
    },
    {
      "accn": "0000950170-24-029298",
      "filed": "2024-03-11",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 939000.0,
        "cash": 226006000.0,
        "eps_diluted": -2.07,
        "free_cash_flow": -60480000.0,
        "net_income": -78715000.0,
        "operating_cash_flow": -59541000.0,
        "operating_income": -78871000.0,
        "stockholders_equity": 272976000.0,
        "total_assets": 298642000.0,
        "total_liabilities": 25666000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.09402291776566438,
        "roa_avg2y": -0.2634198906028556,
        "roa_period_end": -0.2635764560912397,
        "roe_avg2y": -0.2797502274536563,
        "roe_period_end": -0.28835868354727157
      }
    },
    {
      "accn": "0000950170-23-008483",
      "filed": "2023-03-16",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 667000.0,
        "cash": 78446000.0,
        "free_cash_flow": -45935000.0,
        "net_income": -73703000.0,
        "operating_cash_flow": -45268000.0,
        "operating_income": -74186000.0,
        "stockholders_equity": 289776000.0,
        "total_assets": 298997000.0,
        "total_liabilities": 9221000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.03182113080448346,
        "roa_avg2y": -0.3749930041466331,
        "roa_period_end": -0.24650080101138136,
        "roe_avg2y": -0.7381667768363279,
        "roe_period_end": -0.2543447352437745
      }
    },
    {
      "accn": "0000950170-22-004239",
      "filed": "2022-03-21",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 768000.0,
        "cash": 89159000.0,
        "free_cash_flow": -24301000.0,
        "net_income": -26883000.0,
        "operating_cash_flow": -23533000.0,
        "operating_income": -28569000.0,
        "stockholders_equity": -90084000.0,
        "total_assets": 94093000.0,
        "total_liabilities": 6119000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.28570669444060665,
        "roe_avg2y": 0.3479774771859427
      }
    },
    {
      "accn": "0000950170-22-004239",
      "filed": "2022-03-21",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "capex": 525000.0,
        "free_cash_flow": -21208000.0,
        "net_income": -21363000.0,
        "operating_cash_flow": -20683000.0,
        "operating_income": -22371000.0,
        "stockholders_equity": -64426000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roe_avg2y": 0.39547562409174636
      }
    },
    {
      "accn": "0001564590-21-014865",
      "filed": "2021-03-23",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -43611000.0
      },
      "period_end": "2017-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-064005",
    "filed": "2026-02-23",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001796280.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001796280.json"
  },
  "ticker": "ORIC"
}